News About: Pharm. Industry
Daewoong selected as one of world-class companies
The ministry of Knowledge Economy announced Monday that Daewoong Pharmaceutical Co. has been additionally designated as one of the nation’s 300 world-class small- and medium-sized companies.
Last year, the ministry...
Government to back Bukwang’s anticancer drug development
Bukwang Pharmaceutical Co. said Friday that its apatinib mesylate, an investigational cancer drug currently undergoing clinical trials, will receive the government support as part of a government program to cultivate ...
Dongwha’s Yoon unlikely to accept KPMA presidency
Yoon Do-joon, chairman of Dongwha Pharmaceutical Co., expressed his unwillingness to accept the next presidency of the Korea Pharmaceutical Association as Yoon Suk-geun, the incumbent KPMA president offered to resign ...
Sour times for drug makers
Korea’s pharmaceutical companies are feeling another pain under government pressure to refrain from raising OTC (over-the-counter) prices despite soaring oil prices, industry sources said yesterday.
The price of p...
Generic Baraclude developers queue up, but may have to wait
As the patent for Bristol-Myers Squibb (BMS)’s Baraclude (entecavir) is to expires in 2015, Korean pharmaceutical companies are gearing up to push generics into the market.
According to the Korea Food and Drug Admi...
Will health insurance pay for Sorilis?
Will patients with PNH (paroxysmal nocturnal hemoglobinuria) be able to get cheaper and better drugs this year? Now all eyes are on the Ministry for Health, Welfare and Family Affair committee's decision on the price ...
Listed pharmaceutical firms to enjoy better capital ratio
The average equity-to-asset ratio of 55 drug firms listed on Seoul bourse stood at 61 percent, showing better financial structure, according to a report revealed by Yakup.com, a pharmaceutical information company, on ...
KPMA chief steps down
Ilsung Pharma Chairman Yoon Suk-geun said yesterday he will quit his post at the Korea Pharmaceutical Manufacturers Association (KPMA) President.
Yoon took the leadership of the association in February, but he has ...
Pfizer Korea keen on domestic bioequivalence testing
Pfizer Korea, Korean unit of the world's biggest drugmaker, is keenly interested in this country’s bioequivalence testing to increase sales of medicines that have lost patent protection.
In a local symposium organi...
Bloated reserves undermine growth potential
Pharmaceutical companies are piling up internal reserves instead of investing for the future, undermining their growth potential. Companies opted to hold back their capital spending due to the uncertain business outlo...
